Icares Medicus (Taiwan) Performance
| 6612 Stock | TWD 116.50 1.50 1.27% |
The company retains a Market Volatility (i.e., Beta) of 0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Icares Medicus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Icares Medicus is expected to be smaller as well. At this point, Icares Medicus has a negative expected return of -0.44%. Please make sure to check out Icares Medicus' standard deviation, jensen alpha, and the relationship between the coefficient of variation and information ratio , to decide if Icares Medicus performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Icares Medicus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 281.3 M | |
| Total Cashflows From Investing Activities | -6.6 M |
Icares |
Icares Medicus Relative Risk vs. Return Landscape
If you would invest 15,600 in Icares Medicus on September 24, 2024 and sell it today you would lose (3,950) from holding Icares Medicus or give up 25.32% of portfolio value over 90 days. Icares Medicus is generating negative expected returns and assumes 1.8262% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Icares, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Icares Medicus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Icares Medicus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Icares Medicus, and traders can use it to determine the average amount a Icares Medicus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2402
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 6612 |
Estimated Market Risk
| 1.83 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.44 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Icares Medicus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Icares Medicus by adding Icares Medicus to a well-diversified portfolio.
Icares Medicus Fundamentals Growth
Icares Stock prices reflect investors' perceptions of the future prospects and financial health of Icares Medicus, and Icares Medicus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Icares Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0835 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 2.39 B | |||
| Shares Outstanding | 34.16 M | |||
| Price To Earning | 59.67 X | |||
| Price To Book | 3.25 X | |||
| Price To Sales | 5.75 X | |||
| Revenue | 393.92 M | |||
| EBITDA | 102.71 M | |||
| Cash And Equivalents | 301 M | |||
| Cash Per Share | 8.86 X | |||
| Total Debt | 2.8 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 25.38 X | |||
| Cash Flow From Operations | 38.57 M | |||
| Earnings Per Share | 3.88 X | |||
| Total Asset | 965.87 M | |||
About Icares Medicus Performance
Evaluating Icares Medicus' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Icares Medicus has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Icares Medicus has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan.Things to note about Icares Medicus performance evaluation
Checking the ongoing alerts about Icares Medicus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Icares Medicus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Icares Medicus generated a negative expected return over the last 90 days | |
| About 54.0% of the company shares are owned by insiders or employees |
- Analyzing Icares Medicus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Icares Medicus' stock is overvalued or undervalued compared to its peers.
- Examining Icares Medicus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Icares Medicus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Icares Medicus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Icares Medicus' stock. These opinions can provide insight into Icares Medicus' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Icares Stock Analysis
When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.